In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla(KPC) or bla(NDM)

BACKGROUND: It is often challenging to select appropriate combination therapies to treat infections caused by carbapenem-resistant Enterobacterales (CRE) with high-level resistance to carbapenem. METHODS: We investigated the in vitro synergistic activity of ceftazidime-avibactam-, polymyxin- or tige...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuai, Junyang, Zhang, Yawei, Lu, Binghuai, Chen, Hongbin, Zhang, Yulin, Li, Henan, Wang, Yuanyuan, Wang, Qi, Wang, Hui, Wang, Xiaojuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224692/
https://www.ncbi.nlm.nih.gov/pubmed/37249967
http://dx.doi.org/10.2147/IDR.S408228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224692/
https://www.ncbi.nlm.nih.gov/pubmed/37249967
http://dx.doi.org/10.2147/IDR.S408228

Ejemplares similares